MicroRNA-142 protects MC3T3-E1 cells against high glucose-induced apoptosis by targeting β-catenin

Tiansheng Zheng1, Guanglin Ji1, Jincai Chen1

  • 1Department of Orthopedics, The First Affiliated Hospital of Gannan Medical University, Ganzhou, Jiangxi 341000, P.R. China.

Insights

MicroRNA-142 (miR-142) protects bone cells from high glucose-induced apoptosis. This study reveals miR-142 targets beta-catenin, offering a new therapeutic target for osteoporosis.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Background:

  • Osteoporosis involves decreased bone density and mass, leading to fractures.
  • Aberrant microRNA (miRNA) expression is implicated in osteoporosis pathogenesis.
  • The role of miR-142 in osteoporosis development is not fully understood.

Purpose of the Study:

  • To investigate the mechanism of miR-142 in high glucose-induced osteoblast apoptosis.
  • To determine if miR-142 can protect against high glucose-induced apoptosis in MC3T3-E1 cells.
  • To identify the direct target of miR-142 involved in this process.

Main Methods:

  • MC3T3-E1 cells were treated with high glucose.
  • miR-142 mimics and inhibitors were used to modulate miR-142 levels.
  • Apoptosis, Bcl-2, Bax, caspase-3, and beta-catenin expression were assessed.
  • Luciferase reporter assays identified beta-catenin as a direct miR-142 target.

Main Results:

  • High glucose downregulated miR-142 and induced MC3T3-E1 cell apoptosis.
  • miR-142 mimics reduced apoptosis and modulated apoptosis-related proteins (Bcl-2, Bax, caspase-3).
  • Beta-catenin was confirmed as a direct target of miR-142; its overexpression mimicked miR-142 inhibition effects.

Conclusions:

  • miR-142 protects osteoblasts against high glucose-induced apoptosis.
  • This protective effect is mediated by targeting beta-catenin.
  • miR-142 represents a potential therapeutic target for managing high glucose-related bone loss.